You are using an outdated browser. Please upgrade your browser to improve your experience.

Tbio
KRT8
Keratin, type II cytoskeletal 8

Protein Summary
Description
Together with KRT19, helps to link the contractile apparatus to dystrophin at the costameres of striated muscle. This gene is a member of the type II keratin family clustered on the long arm of chromosome 12. Type I and type II keratins heteropolymerize to form intermediate-sized filaments in the cytoplasm of epithelial cells. The product of this gene typically dimerizes with keratin 18 to form an intermediate filament in simple single-layered epithelial cells. This protein plays a role in maintaining cellular structural integrity and also functions in signal transduction and cellular differentiation. Mutations in this gene cause cryptogenic cirrhosis. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jan 2012]
Uniprot Accession IDs
Gene Name
Ensembl ID
  • ENST00000293308
  • ENSP00000293308
  • ENSG00000170421
  • ENST00000546897
  • ENSP00000447402
  • ENST00000552150
  • ENSP00000449404
  • ENST00000552551
  • ENSP00000447566

Symbol
  • CYK8
  • K8
  • KO
  • CK8
  • CK-8
  • CYK8
  • K2C8
  • CARD2
Illumination Graph
Knowledge Table
Most Knowledge About
Knowledge Value (0 to 1 scale)
kinase
0.99
transcription factor perturbation
0.99
interacting protein
0.98
disease perturbation
0.97
hub protein
0.97


Protein Classes
No PANTHER Classes or DTO Classes found
IDG Development Level Summary
Tdark

These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 1095.81   (req: < 5)
Gene RIFs: 123   (req: <= 3)
Antibodies: 3208   (req: <= 50)
Tbio

These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 1095.81   (req: >= 5)
Gene RIFs: 123   (req: > 3)
Antibodies: 3208   (req: > 50)

- OR - satisfy the following criterion:

Gene Ontology Terms: 13
Tchem

Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions

Active Ligand: 0
Tclin

Target has at least one approved drug - AND - satisfies the preceding conditions

Active Drug: 0